x
ServiziMenu principaleHome
You are here: Home > What we do > Past events > 2022 > Improving cancer outcomes and leadership course: an ESO, ECO, SPCC European initiative
Share Print

Description

Chairs: Alexandru Eniu, Razvan Popescu and Peter Selby.

INTRODUCTION

The ESO, ECO and SPCC Improving Outcomes and Leadership course is aimed at helping to tackle the difficult challenge of inequalities in cancer outcomes across Europe.

This training programme will provide mid-career cancer healthcare professionals (of all disciplines), industry professionals, patient advocates and those working in regulatory bodies with the expertise required to develop strategic plans, support and collaborate in relevant applied health research, develop implementation approaches and the skillset to support change management within their countries and regions, in order to improve the quality of care and patient outcomes.

The Training Programme will be developed in close collaboration with patients and patient advocates to ensure that we retain a patient-centred approach. The Training Programme will address overarching issues including early diagnosis, specialised multidisciplinary care, patient-centred approaches, integrated care and the systematic use of existing knowledge. It will engender within participants a clear recognition of the importance of Research and Innovation and clinical trials to 21st century patient care

It is intended that the participants of this course will represent many European countries and that they will remain in contact and develop a network for shared approaches and best practice.
Participants will be asked to share examples showing initiatives and challenges to improve clinical practice in their countries during the course.

Learning Objectives:
  • Build the skills and train individuals to work to improve cancer patient outcomes
  • Share examples of best practice across Europe
  • Create a network of trained individuals who will continue to work together to improve cancer patient outcomes
  • Allow trainees to work together with senior colleagues and European advisors to develop country-specific proposals for improving outcomes
Main Topics:
  • The European Code of Cancer Practice
  • Strategic healthcare improvement skills
  • Awareness and implementation of good practice
  • Innovation based on sound evidence and the appropriate interpretation of RCT data
  • Change management skills

This event is held in partnership with:

European Cancer Organisation
https://www.europeancancer.org/

Sharing Progress in Cancer Care
https://www.spcc.net/

 

Information

Improving Cancer Outcomes and Leadership course will be a combination of the following:

  • Block 1 - 5 pre-event online learning sessions
  • Block 2 - A 3 day in-person event
    Location: Warsaw, Poland
    Dates: 7-9 July 2022

Sessions for both parts of the programme will be sponsored by each contributing organisation. The online learning sessions must be completed by participants before the in-person event.

ACCREDITATION
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 18 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.

ESCO - The ESO College

Being selected to take part in this course is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.The course also enables ESCO members to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the course earns participants 18 ESCO credits.Visit www.ESCO.org for more information on how to join ESCO.

Social media

Use the hashtag #ESOexperience and follow us on Facebook, Twitter and Instagram: @esoncology

Organising Secretariat

Corinne Hall
European School of Oncology
Via Turati 29, 20121, Milan (IT)
Email: chall@eso.net

Dolores Knupfer
European School of Oncology
Piazza Indipendenza 1, Bellinzona (CH)
Email: dknupfer@eso.net

Language

The course will be held in English and translation will not be provided.

Insurance

The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.

 

Application

Participant’s profile
  • Mid-career oncology professionals who have finished training and have a stable position. Involved in or starting to be involved in improving outcomes. Preparing to take on initiatives/leadership responsibilities/managerial roles;
  • Mid-career managers of hospitals or clinics;
  • Mid-career Health Care Professionals with managerial roles;
  • Mid-high-level representatives of patient organisations;
  • Industry representatives;
  • Regulatory bodies.

Priority is given to ESCO Graduates
Fluency in English is required

How to apply

Interested candidates should apply online providing the following:

  • CV & list of publications if oncology professional or affiliation if patient advocate/industry/regulatory body;
  • Motivation letter;
  • Completed template for Examples of initiatives and challenges.
Examples of initiatives and challenges template

Please complete the attached template giving an example of practice that has changed outcomes, or a practice that was implemented to change outcomes but didn’t work. Selected participants will have the opportunity to present their example in the format of a slide presentation (max. 10) to the participants and faculty members during the breakout sessions (as mentioned in the programme). Please don’t submit presentations at this stage in the application process.

ATTENDANCE TO THE COURSE IS BY APPLICATION ONLY

Successful applicants are granted:
- free registration, full board and accommodation

All participants will be expected to reside at the course venue and their full participation is compulsory throughout the course. Travel costs must be covered by the participants themselves.

APPLICATION DEADLINE: 30th March 2022

Programme

Block 1 - 07.06.2022 - On-demand material

Improving cancer outcomes and leadership course: an ESO, ECO & SPCC European initiative - Block 1

Block 2 - 07.07.2022 / 09.07.2022 - Warsaw, Poland

Improving cancer outcomes and leadership course: an ESO, ECO & SPCC European initiative - Block 2

Faculty

Matti Aapro, Clinique de Genolier, Dept. of Breast Center, Genolier, CH
Ajay Aggarwal, London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy, London, UK
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, PT
Andreas Charalambous, What are the benefits of a clinical trial?
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Antonio Tito Fojo, Columbia University, Dept. of Medicine / Division of Medical Oncology, New York, NY, US
Matt Hickey, The Health Value Alliance, Management dept., Surrey, UK
Stein Kaasa, Oslo University Hospital, Department of Oncology, Oslo, NO
Mark Lawler, Queens University Hospital, Centre for Cancer Research and Cell Biology, Belfast, UK
Yolande Lievens, Ghent University Hospital, Radiation Oncology Dept. Ghent, BE
Alexandre Lourenço, Centro Hospitalar e Universitario de Coimbra, Innovation & Development Unit, Coimbra, PT
Kathy Oliver, International Brain Tumour Alliance - IBTA, Patient Advocacy Dpt., Tadworth, Surrey, UK
Razvan Popescu, Tumor Center Aarau / Hirslanden Klinik Aarau, Medical Oncology / Hematology / Palliative Care Dpt., Aarau, CH
Pietro Presti, Fondazione Edo & Elvo Tempia, ., Biella, IT
Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Dept. of Soft Tissue/Bone & Melanoma, Warszawa, PL
Peter Selby, University of Leeds/St. James's University Hospital/European Cancer Concord, Dept. of Cancer Research, Leeds, UK
Richard Sullivan, King's Comprehensive Cancer Centre, Institute of Cancer Policy, London, UK
Nils Wilking, Karolinska Institute, Oncology-Pathology Dept, Stockholm, SE